Table 2. Selected upregulated genes in CDS vs ES.
| Gene name | FC | Gene product |
|---|---|---|
| Muc5ac | 7022.8 | mucin 5, subtypes A and C, tracheobronchial/gastric |
| Zic1 | 6571.5 | zinc finger protein of the cerebellum 1 |
| Crh | 5368.0 | corticotropin releasing hormone |
| Col9a1 | 4165.7 | collagen, type IX, alpha 1 |
| Ccnd2 | 3799.6 | cyclin D2 |
| Vgf | 3596.9 | VGF nerve growth factor inducible |
| Col2a1 | 2948.0 | collagen, type II, alpha 1 |
| Col24a1 | 2010.0 | collagen, type XXIV, alpha 1 |
| Hmga2 | 1941.4 | high mobility group AT-hook 2 |
| Dlk1 | 1899.6 | delta-like 1 homolog (Drosophila) |
| Col4a5 | 1245.3 | collagen, type IV, alpha 5 |
| Fgfbp3 | 1027.0 | fibroblast growth factor binding protein 3 |
| Cdkn1c | 880.8 | cyclin-dependent kinase inhibitor 1C (P57) |
| Gpc3 | 857.8 | glypican 3 |
| Vcan | 771.1 | versican |
| Etv4 | 687.3 | ets variant gene |
| Prg4 | 529.7 | proteoglycan 4 |
| Cldn9 | 338.3 | claudin 9 |
| Ets1 | 322.5 | E26 avian leukemia oncogene 1, 5′ domain |
| Ret | 321.7 | ret proto-oncogene |
| Etv1 | 305.6 | ets variant gene 1 |
| Col13a1 | 283.0 | collagen, type XIII, alpha 1 |
| Col9a3 | 276.9 | collagen, type IX, alpha 3 |
| Ncam1 | 258.8 | neural cell adhesion molecule 1 |
| Fmod | 228.7 | fibromodulin |
| Fndc1 | 216.9 | fibronectin type III domain containing 1 |
| Fli1 | 147.9 | Friend leukemia integration 1 |
| Etv5 | 135.2 | ets variant gene 5 |
| Col11a1 | 117.0 | collagen, type XI, alpha 1 |
| Irf4 | 101.3 | interferon regulatory factor 4 |
| Lmna | 82.7 | lamin A |
| Gpc4 | 77.2 | Glypican 4 |
| Gpc6 | 72.7 | glypican 6 |
| Bcl2 | 51.2 | B-cell leukemia/lymphoma 2 |
| Ccnd1 | 9.4 | cyclin D1 |
| Col5a2 | 6.7 | collagen, type V, alpha 2 |
| Col5a1 | 6.6 | collagen, type V, alpha 1 |
| Ccnd3 | 6.1 | cyclin D3 |
| Fbln2 | 5.3 | fibulin 2 |
| Col3a1 | 5.0 | collagen, type III, alpha 1 |
Genes upregulated in human CDS are underlined.